Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDXNASDAQ:CODXNASDAQ:IINNNASDAQ:SINT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.60$1.78$1.46▼$167.00$2.39M0.38658,718 shs61,887 shsCODXCo-Diagnostics$0.27+4.0%$0.31$0.23▼$2.23$8.57M0.57243,716 shs224,397 shsIINNInspira Technologies OXY B.H.N.$0.83+9.1%$0.61$0.40▼$1.60$9.61M2.12485,870 shs347,572 shsSINTSintx Technologies$3.11+1.3%$2.77$1.71▼$8.60$7.70M0.73932,790 shs20,038 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics0.00%-1.84%-11.60%-57.10%-99.07%CODXCo-Diagnostics+4.04%-1.92%+14.64%-36.27%-80.90%IINNInspira Technologies OXY B.H.N.+9.05%+13.68%+74.72%+11.64%-38.75%SINTSintx Technologies+1.30%-6.89%+15.61%+6.14%-42.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBJDXBluejay Diagnostics1.1057 of 5 stars0.05.00.00.02.80.00.6CODXCo-Diagnostics3.7515 of 5 stars3.53.00.04.40.00.01.3IINNInspira Technologies OXY B.H.N.1.7799 of 5 stars3.53.00.00.00.61.70.0SINTSintx Technologies2.2495 of 5 stars3.52.00.00.03.01.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 0.00N/AN/AN/ACODXCo-Diagnostics 3.00Buy$5.501,971.56% UpsideIINNInspira Technologies OXY B.H.N. 3.00Buy$2.00140.99% UpsideSINTSintx Technologies 3.00Buy$28.00800.32% UpsideCurrent Analyst Ratings BreakdownLatest BJDX, IINN, CODX, and SINT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$2.005/30/2025SINTSintx TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $28.004/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.004/21/2025SINTSintx TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$70.00 ➝ $30.003/28/2025CODXCo-DiagnosticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.00(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay Diagnostics$250K9.54N/AN/A$10.34 per share0.15CODXCo-Diagnostics$3.91M2.28N/AN/A$1.70 per share0.16IINNInspira Technologies OXY B.H.N.N/AN/AN/AN/A$0.34 per shareN/ASINTSintx Technologies$2.89M2.70N/AN/A$2.90 per share1.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$7.72M-$379.74N/A∞N/AN/A-322.46%-262.96%8/13/2025 (Estimated)CODXCo-Diagnostics-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)IINNInspira Technologies OXY B.H.N.-$11.05MN/A0.00∞N/AN/AN/AN/AN/ASINTSintx Technologies-$11.02M-$50.56N/A∞N/A-483.85%-203.66%-104.76%8/4/2025 (Estimated)Latest BJDX, IINN, CODX, and SINT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025SINTSintx Technologies-$0.71-$1.29-$0.58-$1.29$0.73 million$0.37 million5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/A5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 million3/31/2025Q4 2024BJDXBluejay Diagnostics-$36.00-$112.37-$76.37-$112.37N/AN/A3/27/2025Q4 2024CODXCo-Diagnostics-$0.34-$0.36-$0.02-$0.36$0.38 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A2.712.71CODXCo-DiagnosticsN/A4.434.23IINNInspira Technologies OXY B.H.N.0.092.021.89SINTSintx TechnologiesN/A3.443.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%CODXCo-Diagnostics14.99%IINNInspira Technologies OXY B.H.N.12.72%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%CODXCo-Diagnostics6.10%IINNInspira Technologies OXY B.H.N.29.40%SINTSintx Technologies0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableCODXCo-Diagnostics10033.57 million31.53 millionOptionableIINNInspira Technologies OXY B.H.N.2012.62 million8.91 millionNot OptionableSINTSintx Technologies402.51 million2.51 millionNot OptionableBJDX, IINN, CODX, and SINT HeadlinesRecent News About These CompaniesSINTX Technologies stock jumps on deal to acquire SiNAPTIC surgical assetsJune 24 at 5:51 PM | msn.comSINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion MarketJune 24 at 8:30 AM | globenewswire.comMark Lewis Anderson Acquires 10,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) StockJune 24 at 4:53 AM | insidertrades.comSINTX Technologies Announces Strategic Vision Focused on Expansion Across Key SectorsJune 13, 2025 | tmcnet.comSintx Technologies Draws Heavy Retail Buzz On New Patent Push, SubsidiaryMay 23, 2025 | msn.comSINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech MarketMay 22, 2025 | globenewswire.comSiNtx Technologies Inc.May 19, 2025 | marketwatch.comSiNtx Technologies Inc.May 19, 2025 | marketwatch.comSINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device CommercializationMay 16, 2025 | finanznachrichten.deMark Lewis Anderson Purchases 5,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) StockMay 15, 2025 | insidertrades.comSINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device CommercializationMay 15, 2025 | globenewswire.comSintx Technologies, Inc. (NASDAQ:SINT) Insider Gregg R. Honigblum Buys 10,000 SharesMay 1, 2025 | insidertrades.comSintx Technologies Appoints Five New Board DirectorsApril 8, 2025 | tipranks.comSintx Technologies announces changes to board, Chairman Bal to retireApril 5, 2025 | markets.businessinsider.comSINTX Technologies Announces Strategic Changes to Board of DirectorsApril 3, 2025 | markets.businessinsider.comSINTX: Peer-reviewed Study Shows Biomechanical Advantages Of Silicon Nitride In ACDF ProceduresMarch 21, 2025 | nasdaq.comMaxim Group Reaffirms Their Hold Rating on Sintx Technologies (SINT)March 21, 2025 | markets.businessinsider.comSintx Technologies announces publication of study on silicon nitride in ACDFMarch 20, 2025 | markets.businessinsider.comSintx Technologies files to sell 3.01M shares of common stock for holdersMarch 20, 2025 | markets.businessinsider.comSINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine FusionMarch 19, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBJDX, IINN, CODX, and SINT Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.60 0.00 (0.00%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$1.54 -0.06 (-3.50%) As of 04:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Co-Diagnostics NASDAQ:CODX$0.27 +0.01 (+4.04%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$0.27 +0.01 (+2.07%) As of 06/24/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Inspira Technologies OXY B.H.N. NASDAQ:IINN$0.83 +0.07 (+9.05%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$0.82 -0.01 (-0.95%) As of 06/24/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Sintx Technologies NASDAQ:SINT$3.11 +0.04 (+1.30%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$3.11 0.00 (0.00%) As of 04:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
